Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex.

Titel:: Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex.
Dokumenttyp:: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
Autor(en):: Wienecke, R; Fackler, I; Linsenmaier, U; Mayer, K; Licht, T; Kretzler, M
Abstract:: A 19-year old patient with tuberous sclerosis presented with a renal angiomyolipoma. Because animal trials of tuberous sclerosis showed an effect of rapamycin on renal tumors, our patient was administered rapamycin for 6 months. During this time, the renal angiomyolipoma shrank significantly, regrew during an 8-month period, and decreased in size again after readministration of rapamycin.
Zeitschriftentitel:: Am J Kidney Dis
Jahr:: 2006
Band / Volume:: 48
Heft / Issue:: 3
Seitenangaben Beitrag:: e27-9
Sprache:: eng
Volltext / DOI:: doi:10.1053/j.ajkd.2006.05.018
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/16931204
Print-ISSN:: 0272-6386
TUM Einrichtung:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Vorkommen: